{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:08:29Z","timestamp":1693516109337},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,15]]},"DOI":"10.2146\/ajhp160943","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T14:05:16Z","timestamp":1499436316000},"page":"1076-1083","source":"Crossref","is-referenced-by-count":6,"title":["Influence of drug class and healthcare setting on systemic antifungal expenditures in the United States, 2005\u201315"],"prefix":"10.1093","volume":"74","author":[{"given":"Margaret A.","family":"Fitzpatrick","sequence":"first","affiliation":[{"name":"Department of Veterans Affairs, Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. VA Hospital, Hines, IL, and Department of Medicine, Division of Infectious Diseases, Loyola University Chicago Stritch School of Medicine, Maywood, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie J.","family":"Suda","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs, Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. VA Hospital, Hines, IL, and Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago College of Pharmacy, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlesnika T.","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs, Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. VA Hospital, Hines, IL, and Department of Preventive Medicine, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Hunkler","sequence":"additional","affiliation":[{"name":"QuintilesIMS, Professor Relations, Fountain Hills, AZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Weaver","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs, Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. VA Hospital, Hines, IL, and Department of Public Health Sciences, Loyola University Chicago Stritch School of Medicine, Maywood, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen T.","family":"Schumock","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041103310472600_b1-0741076","unstructured":"Review on antimicrobial resistance. Tackling drug-resistant infections globally: final report and recommendations (May2016). http:\/\/amr-review.org\/sites\/default\/files\/160518_Finalpaper_withcover.pdf (accessed 2016 May 25)."},{"key":"key\n\t\t\t\t2019041103310472600_b2-0741076","first-page":"194","article-title":"Vital signs: improving antibiotic use among hospitalized patients","volume":"63","author":"Fridkin","year":"2014","journal-title":"MMWR."},{"key":"key\n\t\t\t\t2019041103310472600_b3-0741076","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/jgs.12099","article-title":"Another setting for stewardship: high rate of unnecessary antimicrobial use in a Veterans Affairs long-term care facility","volume":"61","author":"Peron","year":"2013","journal-title":"J Am Geriatr Soc."},{"key":"key\n\t\t\t\t2019041103310472600_b4-0741076","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010\u20132011","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA."},{"key":"key\n\t\t\t\t2019041103310472600_b5-0741076","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis."},{"key":"key\n\t\t\t\t2019041103310472600_b6-0741076","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv163","article-title":"Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008\u20132014","volume":"2","author":"Vallabhaneni","year":"2015","journal-title":"Open Forum Infect Dis."},{"issue":"suppl 1","key":"key\n\t\t\t\t2019041103310472600_b7-0741076","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki218","article-title":"Changing patterns and trends in systemic fungal infections","volume":"56","author":"Richardson","year":"2005","journal-title":"J Antimicrob Chemother."},{"key":"key\n\t\t\t\t2019041103310472600_b8-0741076","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N Engl J Med."},{"issue":"suppl 2","key":"key\n\t\t\t\t2019041103310472600_b9-0741076","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/myc.12329","article-title":"Antifungal stewardship in daily practice and health economic implications","volume":"58","author":"Munoz","year":"2015","journal-title":"Mycoses."},{"key":"key\n\t\t\t\t2019041103310472600_b10-0741076","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/jac\/dks256","article-title":"Adherence to recommendations for the use of antifungal agents in a tertiary care hospital","volume":"67","author":"Nivoix","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"key\n\t\t\t\t2019041103310472600_b11-0741076","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/587633","article-title":"Inappropriate use of antifungal medications in a tertiary care center in Thailand: a prospective study","volume":"29","author":"Sutepvarnon","year":"2008","journal-title":"Infect Control Hosp Epidemiol."},{"key":"key\n\t\t\t\t2019041103310472600_b12-0741076","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/QCO.0b013e32834e0680","article-title":"The case for antifungal stewardship","volume":"25","author":"Ananda-Rajah","year":"2012","journal-title":"Curr Opin Infect Dis."},{"key":"key\n\t\t\t\t2019041103310472600_b13-0741076","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis."},{"key":"key\n\t\t\t\t2019041103310472600_b14-0741076","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2146\/ajhp140849","article-title":"National trends in prescription drug expenditures and projections for 2015","volume":"72","author":"Schumock","year":"2015","journal-title":"Am J Health-Syst Pharm."},{"key":"key\n\t\t\t\t2019041103310472600_b15-0741076","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2146\/ajhp160205","article-title":"National trends in prescription drug expenditures and projections for 2016","volume":"73","author":"Schumock","year":"2016","journal-title":"Am J Health-Syst Pharm."},{"key":"key\n\t\t\t\t2019041103310472600_b16-0741076","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dks445","article-title":"A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009","volume":"68","author":"Suda","year":"2013","journal-title":"J Antimicrob Chemother."},{"key":"key\n\t\t\t\t2019041103310472600_b17-0741076","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/MAJ.0000000000000412","article-title":"Echinocandin use in hospitalized patients: a multi-institutional study","volume":"349","author":"Garey","year":"2015","journal-title":"Am J Med Sci."},{"key":"key\n\t\t\t\t2019041103310472600_b18-0741076","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/jac\/dku053","article-title":"Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed","volume":"69","author":"Valerio","year":"2014","journal-title":"J Antimicrob Chemother."},{"key":"key\n\t\t\t\t2019041103310472600_b19-0741076","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2710.2010.01166.x","article-title":"Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology","volume":"36","author":"Des Champs-Bro","year":"2011","journal-title":"J Clin Pharm Ther."},{"key":"key\n\t\t\t\t2019041103310472600_b20-0741076","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw151","article-title":"Cryptococcal meningitis treatment strategies affected by the explosive cost of flucytosine in the United States: a cost-effectiveness analysis","volume":"62","author":"Merry","year":"2016","journal-title":"Clin Infect Dis."},{"key":"key\n\t\t\t\t2019041103310472600_b21-0741076","volume-title":"National sales perspectives [proprietary database]","author":"IMS Health","year":"2015"},{"key":"key\n\t\t\t\t2019041103310472600_b22-0741076","unstructured":"IMS Health. The uniform system of classification. www.imshealth.com\/files\/web\/IMSH%20Institute\/USC_Classification_Process_2011.pdf (accessed 2016 Jan 1)."},{"key":"key\n\t\t\t\t2019041103310472600_b23-0741076","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2146\/ajhp130767","article-title":"National trends in prescription drug expenditures and projections for 2014","volume":"71","author":"Schumock","year":"2014","journal-title":"Am J Health-Syst Pharm."},{"key":"key\n\t\t\t\t2019041103310472600_b24-0741076","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001\u20132010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg Infect Dis."},{"key":"key\n\t\t\t\t2019041103310472600_b25-0741076","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis."},{"key":"key\n\t\t\t\t2019041103310472600_b26-0741076","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.idc.2015.10.012","article-title":"Antifungal agents: spectrum of activity, pharmacology, and clinical indications","volume":"30","author":"Nett","year":"2016","journal-title":"Infect Dis Clin North Am."},{"key":"key\n\t\t\t\t2019041103310472600_b27-0741076","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/phar.1652","article-title":"Isavuconazole: pharmacology, pharmacodynamics, and current clinical experience with a new triazole antifungal agent","volume":"35","author":"Rybak","year":"2015","journal-title":"Pharmacotherapy."},{"key":"key\n\t\t\t\t2019041103310472600_b28-0741076","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2146\/ajhp080325","article-title":"Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients","volume":"66","author":"Menzin","year":"2009","journal-title":"Am J Health-Syst Pharm."},{"key":"key\n\t\t\t\t2019041103310472600_b29-0741076","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.ajic.2010.06.009","article-title":"The economic costs to United States hospitals of invasive fungal infections in transplant patients","volume":"39","author":"Menzin","year":"2011","journal-title":"Am J Infect Control."},{"key":"key\n\t\t\t\t2019041103310472600_b30-0741076","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-5-1","article-title":"Hospital use of systemic antifungal drugs","volume":"5","author":"De With","year":"2005","journal-title":"BMC Clin Pharmacol."},{"key":"key\n\t\t\t\t2019041103310472600_b31-0741076","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2147\/CEOR.S92455","article-title":"The expenditures related to the use of antifungal drugs in patients with hematological cancers: a cost analysis","volume":"7","author":"Gedik","year":"2015","journal-title":"Clinicoecon Outcomes Res."},{"key":"key\n\t\t\t\t2019041103310472600_b32-0741076","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s15010-015-0742-5","article-title":"Hospital use of systemic antifungal drugs: a multi-center surveillance update from Germany","volume":"43","author":"Gross","year":"2015","journal-title":"Infection."},{"key":"key\n\t\t\t\t2019041103310472600_b33-0741076","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis."},{"key":"key\n\t\t\t\t2019041103310472600_b34-0741076","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.clinthera.2012.09.003","article-title":"Trends in the utilization of, spending on, and prices for outpatient antifungal agents in US Medicaid programs: 1991\u20132009","volume":"34","author":"Desai","year":"2012","journal-title":"Clin Ther."},{"key":"key\n\t\t\t\t2019041103310472600_b35-0741076","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/368091","article-title":"The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992\u20132000","volume":"36","author":"Mirza","year":"2003","journal-title":"Clin Infect Dis."},{"key":"key\n\t\t\t\t2019041103310472600_b36-0741076","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jac\/dkv373","article-title":"Validating hospital antibiotic purchasing data as a metric of inpatient antibiotic use","volume":"71","author":"Tan","year":"2016","journal-title":"J Antimicrob Chemother."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/74\/14\/1076\/28336142\/ajhp1076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T20:36:00Z","timestamp":1569702960000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/74\/14\/1076\/5102599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,15]]},"references-count":36,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,7,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp160943","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,15]]},"published":{"date-parts":[[2017,7,15]]}}}